Antithrombin Alfa Completed Phase 1 Trials for Congenital Antithrombin Deficiency

IndicationsStatusPurposePhase
CompletedNot Available1
clinicaltrials.gov IdentifierTitleDrugs
NCT00938288A Study of KW-3357 in Congenital Antithrombin Deficiency